Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in non-diabetic progressive CKD
NCT03831464Phase 3Active, not recruiting
- Sponsor
- University of Antwerp
- Start
- Nov 2019
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in chronic kidney disease (CKD), sponsored by University of Antwerp. Started Nov 2019; status: active, not recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT03831464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03831464.